Assessment of efficiency and the safety of Ovariamin® drug in normalization of menstrual cycle

Abstract

We performed an open controlled trial of efficiency and the safety of Ovariamin^® drug in treatment of menstrual disorders. The research included 33 patients with menstrual disorder which were divided into 2 groups: the 1st group - menstrual disorders /ICD10/N91. The absent scanty and infrequent menstruation (n = 17); the 2nd group - menstrual disorders /ICD10/ N92. Abundant, frequent and irregular menstruations (n = 16). The analysis of clinical efficiency of administration of Ovariamin^® drug in 3 months showed the following: normalization of menstrual cycle in the 1st group was registered in 52.9% of patients, in the 2nd group - in 62.5%; decrease of menstrual pain was registered in 52.9% in the 1st group and in 62.5% in the 2nd group. Satisfaction of patients in the end of the therapy was revealed in 88.2% in the 1st group, and in 93.8% in the 2nd group respectively; efficiency in maintenance of regular menstrual cycle in the next 6 months after treatment was revealed in 76.5% of patients of the 1st group, and in 75% of the 2nd group of patients.